Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
143860 ETF · Mirae Asset TIGER HEALTH CARE ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -4.56%  | -14.53% | +26.06%  | +63.53%  | +2.53% | -7.11% | -6.73% | -6.55% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -14.53% | +26.06% | +63.53% | +2.53% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 143860 ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
143860’s has a Final Sustainability Grade of either B+, B, or B-.
Replication
Issuer
| AuM | ||
|---|---|---|
396500 | Mirae Asset TIGER Fn Semiconductor TOP10 ETF | €7.47B |
102110 | Mirae Asset TIGER 200 ETF | €6.08B |
133690 | Mirae Asset TIGER NASDAQ 100 ETF | €5.79B |
381170 | Mirae Asset TIGER US Tech TOP10 INDXX ETF | €2.47B |
292150 | MIRAE ASSET TIGER TOP 10 ETF | €1.47B |
Frequently asked questions about 143860
What does Mirae Asset TIGER HEALTH CARE ETF, 143860, invest in?
143860 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.
Which benchmark or index does 143860 replicate?
143860 tracks the Korea KRX Health Care Index - KRW, through a full replication replication method.
What is the Total Expense ratio (TER) of 143860?
143860 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
When was 143860 launched?
143860 was introduced to the market on July 18, 2011. It trades on Macedonia, The Former Yugoslav Republic of, among other exchanges
Who is the ETF issuer of 143860?
Mirae Asset TIGER HEALTH CARE ETF, 143860, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.
What is the current assets under management (AUM) of 143860?
143860 oversees €104M in assets as of May 11, 2026.
How has 143860 performed lately?
Based on data from May 11, 2026, 143860 returned -4.56% over the past month, -14.53% over the last three months and -6.55% year-to-date.
What are the latest inflows or outflows for 143860?
As of May 11, 2026, 143860 recorded net flows of +€439K over the last month and -€34M year-to-date.
Does 143860 distribute dividends?
143860 follows a distributing dividend policy, meaning it pays out income to investors. As of May 11, 2026, its 12-month trailing yield was 0.16%.
What are the main country or region exposures of 143860?
As of March 31, 2026, 143860 has significant geographic allocations in Republic of Korea.
In which sector or theme does 143860 invest in?
As of March 31, 2026, 143860 focuses largely on Health Care and Consumer Discretionary.
How many securities does 143860 hold and how diversified is it?
As of March 31, 2026, 143860 holds 64 positions in its portfolio, with 75.26% of assets concentrated in its top 15 holdings.
What are the main positions in 143860?
As of March 31, 2026, 143860 top three holdings include CELLTRION, SAMSUNG BIOLOGICS CO LTD and ALTEOGEN INC.
What is the base currency of 143860?
The base currency of 143860 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
